TransMedics (TMDX) Long-Term Deferred Tax (2025 - 2026)
TransMedics' quarterly Long-Term Deferred Tax came in at $82.5 million in Q1 2026, down 1.28% quarter-over-quarter from $83.5 million in Q4 2025.
TransMedics has reported Long-Term Deferred Tax for 2 years, with the latest figure at $82.5 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $82.5 million; the trailing twelve-month figure through Mar 2026 stood at $82.5 million (changed N/A YoY), and the FY2025 full-year result was $83.5 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $82.5 million, down from $83.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $83.5 million in Q4 2025, with the low at $82.5 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.48 Mn |
| Dec 31, 2025 | 83.54 Mn |